Product Information
TEMOZOLOMIDE 140 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $11.4609 per EA under NDC 16571081941. Its NADAC has been published 100 times since Apr 17, 2024.
Strength
140 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571081941
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/18/2025
Active Ingredients
TEMOZOLOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206309On Market Since
10/4/2022
Pharmacological Classes
Price Statistics
The NADAC for TEMOZOLOMIDE 140 MG CAPSULE has been published 100 times since Apr 17, 2024, and over the history we have for it it has risen 6.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.4609 per EA |
|---|---|
| All-time high | $12.1860 (Jun 11, 2025) |
| All-time low | $6.5705 (Aug 21, 2024) |
| 52-week high | $11.4609 |
| 52-week low | $11.4609 |
| Median price | $10.7251 |
| Average price | $10.1181 |
| Largest weekly change | -38.7% (Aug 21, 2024) |
| Weeks tracked | 100 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 28% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TEMOZOLOMIDE 140 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMOZOLOMIDE 140 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $11.4609 per EA (NDC 16571081941), effective Mar 11, 2026.
How has the price of TEMOZOLOMIDE 140 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMOZOLOMIDE 140 MG CAPSULE has risen 6.9%. It has been tracked across 100 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for TEMOZOLOMIDE 140 MG CAPSULE?
Since Apr 17, 2024, the NADAC for TEMOZOLOMIDE 140 MG CAPSULE has ranged from a low of $6.5705 (Aug 21, 2024) to a high of $12.1860 (Jun 11, 2025), with a median of $10.7251 per EA.
Are there cheaper alternatives to TEMOZOLOMIDE 140 MG CAPSULE?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TEMOZOLOMIDE 140 MG CAPSULE, is $8.3047 per EA — about 28% below TEMOZOLOMIDE 140 MG CAPSULE.
Who manufactures TEMOZOLOMIDE 140 MG CAPSULE?
TEMOZOLOMIDE 140 MG CAPSULE (NDC 16571081941) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification